PNV Media Thread, page-2310

Apologies if this has already been posted. Unlike Hottod, I struggle to keep track of these things and it just came up on my feed even though its from last month.. (Note: Graphic Pics)

Fes

(PDF) Microsurgical Reconstruction of Foot Defects: A Case Series with Long-Term Follow-Up (researchgate.net)

In our clinic, the frequency of free flaps for reconstruction of foot defects has decreased due to the possibility of reconstructing complex defects, even in weight-bearing areas (such as the heel) using innovative treatment options from the field of dermal skin substitutes. A meta-analysis showed a reduced amputation rate in diabetic foot ulcers when treated with skin substitutes [29]. With NovoSorb® Biodegradable Temporising Matrix (BTM) (Poly-medics Innovations GmbH, Denkendorf, Germany), even deep wounds can be treated [30].However, skin substitutes, such as BTM, also have their limitations, notably in cases of poor vascularization or possible infectious events in the defect area, for example [30]. Following these findings, there may be a future balancing act between novel skin substitutes and autologous reconstruction procedures for large defects of the foot [19]. Influencing factors, such as comorbidities, status of bones, and the threat of losing another limb in the near future, need to be considered before choosing the best treatment option for every individual patient [31]. In principle, however, flap reconstructions are suitable for threatened ischemic lower extremities (in combination with revascularization procedures), traumatic defects(including burns), tumors, and infections

In our clinic, the frequency of free flaps for reconstruction of foot defects has decreased

due to the possibility of reconstructing complex defects, even in weight-bearing areas (such

as the heel) using innovative treatment options from the field of dermal skin substitutes. A

meta-analysis showed a reduced amputation rate in diabetic foot ulcers when treated with

skin substitutes [

29

].With NovoSorb

®

Biodegradable Temporising Matrix (BTM) (Poly-

medics Innovations GmbH, Denkendorf, Germany), even deep wounds can be treated [

30

].

However, skin substitutes, such as BTM, also have their limitations, notably in cases of poor

vascularization or possible infectious events in the defect area, for example [

30

]. Following

these findings, there may be a future balancing act between novel skin substitutes and

autologous reconstruction procedures for large defects of the foot [

19

]. Influencing factors,

such as comorbidities, status of bones, and the threat of losing another limb in the near

future, need to be considered before choosing the best treatment option for every individual

patient [

31

]. In principle, however, flap reconstructions are suitable for threatened ischemic

lower extremities (in combination with revascularization procedures), traumatic defects

(including burns), tumors, and infections